Evolving treatment strategies for EGFRex20ins-mutated NSCLC: a comprehensive review of Amivantamab’s role and future directions
Sign Up to like & getrecommendations! Published in 2025 at "ecancermedicalscience"
DOI: 10.3332/ecancer.2025.2037
Abstract: Epidermal growth factor receptor exon 20 insertion mutations (EGFRex20ins) are a unique molecular subtype of non-small cell lung cancer (NSCLC) linked to resistance to EGFR tyrosine kinase inhibitors of the first and second generations. Until… read more here.
Keywords: treatment strategies; treatment; egfrex20ins mutated; review ... See more keywords